(Q39178990)

9 September 2017

title

miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma (English)

1 reference

9 September 2017

Lei Chen

1

1 reference

9 September 2017

Qing Wang

2

1 reference

9 September 2017

Guo-dong Wang

3

1 reference

9 September 2017

Hua-song Wang

4

1 reference

9 September 2017

Yong Huang

5

1 reference

9 September 2017

Xi-ming Liu

6

1 reference

9 September 2017

Xian-hua Cai

7

1 reference

9 September 2017

language of work or name

English

0 references

publication date

15 March 2013

1 reference

9 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

9 September 2017

volume

587

1 reference

9 September 2017

issue

9

1 reference

9 September 2017

page(s)

1366-1372

1 reference

The epidemiology of osteosarcoma

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

Many roads to maturity: microRNA biogenesis pathways and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

miRNA signatures associate with pathogenesis and progression of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

miR-15a and miR-16-1 down-regulation in pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

miR-15 and miR-16 induce apoptosis by targeting BCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

miR-15a and miR-16-1 in cancer: discovery, function and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

A microarray-based approach identifies ADP ribosylation factor-like protein 2 as a target of microRNA-16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

Mitogen-activated protein kinase pathway in osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.03.007

10.1016/J.FEBSLET.2013.03.007

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference